Strategies to improve antimicrobial utilization with a special focus on developing countries
Antimicrobial resistance (AMR) is a high priority across countries as it increases morbidity,
mortality and costs. Concerns with AMR have resulted in multiple initiatives internationally …
mortality and costs. Concerns with AMR have resulted in multiple initiatives internationally …
Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015)
R Ofori-Asenso, P Brhlikova, AM Pollock - BMC public health, 2016 - Springer
Background Rational medicine use is essential to optimize quality of healthcare delivery and
resource utilization. We aim to conduct a systematic review of changes in prescribing …
resource utilization. We aim to conduct a systematic review of changes in prescribing …
Barriers for access to new medicines: searching for the balance between rising costs and limited budgets
B Godman, A Bucsics, P Vella Bonanno… - Frontiers in Public …, 2018 - frontiersin.org
Introduction: There is continued unmet medical need for new medicines across countries
especially for cancer, immunological diseases, and orphan diseases. However, there are …
especially for cancer, immunological diseases, and orphan diseases. However, there are …
Key issues surrounding appropriate antibiotic use for prevention of surgical site infections in low-and middle-income countries: a narrative review and the implications
Background There is a concern with the growing use of antimicrobials across countries
increasing antimicrobial resistance (AMR) rates. A key area within hospitals is their use for …
increasing antimicrobial resistance (AMR) rates. A key area within hospitals is their use for …
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
B Godman, RE Malmström, E Diogene… - Expert review of …, 2015 - Taylor & Francis
Medicines have made an appreciable contribution to improving health. However, even high-
income countries are struggling to fund new premium-priced medicines. This will grow …
income countries are struggling to fund new premium-priced medicines. This will grow …
Evidence-based public policy making for medicines across countries: findings and implications for the future
Aim: Global expenditure on medicines is rising up to 6% per year driven by increasing
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …
Validity of World Health Organisation prescribing indicators in Namibia's primary healthcare: findings and implications
Abstract Objective World Health Organization/International Network of Rational use of Drugs
(WHO/INRUD) indicators are widely used to assess medicine use. However, there is limited …
(WHO/INRUD) indicators are widely used to assess medicine use. However, there is limited …
The current situation regarding long-acting insulin analogues including biosimilars among African, Asian, European, and South American countries; findings and …
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of
associated complications has appreciably increased global expenditure in recent years. The …
associated complications has appreciably increased global expenditure in recent years. The …
Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review
Pharmaceutical expenditure has increased rapidly across many Organisation for Economic
Cooperation and Development (OECD) countries over the past three decades. This growth …
Cooperation and Development (OECD) countries over the past three decades. This growth …
The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians
Generic medicines have the same efficacy and safety as originators at lower prices;
however, there are concerns with their utilization in Nigeria. Objective was to evaluate …
however, there are concerns with their utilization in Nigeria. Objective was to evaluate …